CSI Market
Sign In | Register

Nurix Therapeutics Inc (NRIX) Annual Balance Sheets

Annual · GAAP · USD millions
Access NRIX quarterly Balance Sheets →
Tracking balance sheet results across Nurix Therapeutics Inc to Nov 30 2021 helps illustrate how Nov 30 2025's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Nov 30 2025)
(Nov 30 2024) (Nov 30 2023) (Nov 30 2022) (Nov 30 2021)
Assets
Cash & cash equivalent246.96
Marketable Securities, Current SH0.00
Cash & Short-term Investments246.00
Accounts receivable0.00
Other Current Assets345.98
Prepaid Expense And Other Assets Current13.88
Total Current Assets606.82
Equipment/Property/Plant Net22.49
Long-term investments0.00
Income Taxes Receivable PR0.00
Other Assets, Noncurrent58.83
Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Current-
Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Noncurrent-
Debt Securities Available For Sale Excluding Accrued Interest Current345.98
Restricted Cash Noncurrent0.97
Total Assets688.14
Liabilities
Accounts Payable, Current AC11.22
Other Liabilities, Current75.26
Total Current Liabilities86.47
Total Long-term Debt0.00
Other liabilities, Noncurrent62.92
Contract With Customer Liability Current17.58
Contract With Customer Liability Noncurrent10.01
Total Liabilities149.39
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock1,541.77
Retained Earnings / Accumulated Deficit-1,003.23
Other Equity0.10
Common Stockholder's Equity538.75
Total Stockholder's Equity538.75
Liabilities & Stockholder's Equity688.14
4 historic quarters locked

Sign in to unlock the full Nurix Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Nurix Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001549595-26-000016

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License